LiliPeptideMOTS-c
Ordered MOTS-c from LiliPeptide? Mail in a sample (US only) and let us test it.
Test my supplyLiliPeptide MOTS-c shows mixed evidence: early 99.9% purity passes gave way to 98.8% and repeated 98.2% misses. The latest vial recovered to 99.7% with +2% fill and batch info, but mid-run purity and batch-ID gaps temper confidence.
Public records and web artifacts leave the listed U.S. location unsupported and point toward a China/Hong Kong operating stack. The report maps the typo-domain network, PeptSlim/ElitePeptide66 overlap, rotating contact personas and post-payment courier-fee complaints.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including LiliPeptide rows.
Cancel anytime
About LiliPeptide test results from Finnrick
LiliPeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 15 peptides and 336 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible LiliPeptide peptides in this dataset are BPC-157 (24 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.
Ordered MOTS-c from LiliPeptide? Mail in a sample (US only) and let us test it.
Test my supply